Responses

Download PDFPDF

Helicobacter pylori infection and long term proton pump inhibitor therapy
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Helicobacter pylori and long term proton pump inhibitor therapy
    • Ernst J Kuipers, MD
    • Other Contributors:
      • Elly C. Klinkenberg-Knol, Anders Walan

    Dear Editor

    With interest did we read the editorial of Dr Ken McColl [1] pertaining to our publication in the January issue on cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with omeprazole.

    We highly regard Dr McColl as an experienced clinical scientist and good friend. Nevertheless, we consider some of his editorial comments inaccurate and asking for a response....

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Hypergastrinemia in patients infected with Helicobacter pylori, treated with proton pump inhibitors

    Dear Editor

    We read with interest the commentaries by McColl: Helicobacter pylori infection and long term proton pump inhibitor therapy.[1]

    It is remarkable that he did not mention gastrin at all although hypergastrinemia is a result of reduced gastric acidity [2] as well as Helicobacter pylori (HP) infection,[3] and that patients with HP infection treated with proton pump inhibitors (PPI) have additive...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    H pylori infection and reflux oesophagitis
    • Jannis Kountouras, Associate Professor of Medicine, Gastroenterologist
    • Other Contributors:
      • Christos Zavos, Dimitrios Chatzopoulos

    Dear Editor

    We read with considerable interest Dr Kuipers' paper [1], that found no significant adverse impact on the severity of reflux disease or its control after two-year omeprazole therapy following H pylori (Hp) eradication, during which time gastritis largely healed. In the commentary by Dr McColl [2] it is stated that, although published data are conflicting, Schwizer et al. reported improvement i...

    Show More
    Conflict of Interest:
    None declared.